Analytical Data
-
Gene name
TDGF1
- Application
-
Alternative Names
Cripto-1 growth factor ;CRGFEpidermal growth factor-like cripto protein CR1
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P13385
-
Expression Region
32-150aa
-
Molecular Weight
17.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TDGF1, also known as Teratocarcinoma-Derived Growth Factor 1, is a protein that plays a crucial role in embryonic development and cell signaling. It is primarily involved in the regulation of cellular processes such as differentiation, proliferation, and apoptosis, making it a significant focus in developmental biology and regenerative medicine. Research indicates that TDGF1 is associated with various biological functions, including the promotion of stem cell properties and the modulation of immune responses. Studies have suggested that TDGF1 may be implicated in several pathological conditions, including cancer, where altered expression levels can affect tumor progression and metastasis. Thus, understanding TDGF1's structural characteristics and functional mechanisms is vital for exploring its potential therapeutic applications. Recombinant TDGF1 proteins have been generated for various studies to elucidate their role in disease and normal physiology. By employing techniques such as gene cloning, expression systems, and purification methods, researchers aim to investigate TDGF1 interactions with other cellular molecules and its impact on signaling pathways. Additionally, the availability of recombinant TDGF1 opens avenues for drug development and innovative treatments in regenerative therapies and oncology, highlighting its importance as a biomarker and therapeutic target. Overall, the study of TDGF1 recombinant proteins holds significant promise for advancing our understanding of developmental processes and addressing complex diseases.
